Jazz Pharmaceuticals plc — Director's Dealing 2014

May 29, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-05-27

Reporting Person: Hooper Suzanne Sawochka (EVP and General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-27	Ordinary Shares	M	667	$46.83	Acquired	57802	Direct
2014-05-27	Ordinary Shares	S	667	$140.00	Disposed	57135	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-05-27	Nonstatutory Stock Option (right to buy)	$46.83	M	667	Disposed	2022-08-08	Ordinary Shares (667)	Direct

Footnotes

F1: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: Following the reported transaction, the remaining ordinary shares subject to this option are vested with respect to 26,266 shares and will vest with respect to 24,328 shares in nineteen equal monthly installments from June 9, 2014 to December 9, 2015 and with respect to 9,532 shares in eight equal monthly installments from January 9, 2016 to August 9, 2016.